3,3-dimethyl-6-(2-methylpyrimidin-5-yl)-1-(1H-pyrrolo[2,3-c]pyridin-4-yl)indolin-2-one

ID: ALA4212469

PubChem CID: 129104202

Max Phase: Preclinical

Molecular Formula: C22H19N5O

Molecular Weight: 369.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncc(-c2ccc3c(c2)N(c2cncc4[nH]ccc24)C(=O)C3(C)C)cn1

Standard InChI:  InChI=1S/C22H19N5O/c1-13-25-9-15(10-26-13)14-4-5-17-19(8-14)27(21(28)22(17,2)3)20-12-23-11-18-16(20)6-7-24-18/h4-12,24H,1-3H3

Standard InChI Key:  GXJMSBHSODGFPG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    6.4096   -1.3248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4137   -2.1420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1194   -1.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2207   -2.4061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2196   -3.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9276   -3.6346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9258   -1.9973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5135   -3.6340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8058   -3.2231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0982   -3.6305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0972   -4.4485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8095   -4.8575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5141   -4.4478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6345   -2.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6393   -3.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4237   -3.4755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9037   -2.8067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7209   -2.8015    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4086   -4.2929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6918   -4.6878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6765   -5.5040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3771   -5.9264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3897   -4.8575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1065   -4.7115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0904   -5.5220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8562   -5.7878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3457   -5.1415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8822   -4.4765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6 15  2  0
 14  7  2  0
  7  4  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  5  8  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17  2  1  0
  2 14  1  0
 17 18  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 25  1  0
 24 19  1  0
 16 19  1  0
 11 23  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4212469

    ---

Associated Targets(non-human)

Slc29a1 Equilibrative nucleoside transporter 1 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.43Molecular Weight (Monoisotopic): 369.1590AlogP: 4.28#Rotatable Bonds: 2
Polar Surface Area: 74.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.66CX Basic pKa: 4.77CX LogP: 2.88CX LogD: 2.88
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -0.32

References

1. Rosse G..  (2017)  Indolinone Inhibitors of ENT1 for the Treatment of Schizophrenia.,  (10): [PMID:29057039] [10.1021/acsmedchemlett.7b00378]

Source